Institute of Tropical Medicine Antwerp
Foundation of Public Utility

Browsing B. Department of Clinical Sciences (1990-present) by Keyword "Reverse transcriptase inhibitors"

DSpace/Manakin Repository

Browsing B. Department of Clinical Sciences (1990-present) by Keyword "Reverse transcriptase inhibitors"

Sort by: Order: Results:

Title Author(s) Journal Issue Date Type
Development and characterization of a solid dispersion film for the vaginal application of the anti-HIV microbicide UAMC01398 Grammen, C.; van den Mooter, G.; Appeltans, B.; Michiels, J.; Crucitti, T.; Ariën, K. K.; Augustyns, K.; Augustijns, P.; Brouwers, J. International Journal of Pharmaceutics 2014 Article
Analysis of lipid levels and changes in body fat distribution in treatment-naïve, HIV-1-infected adults treated with rilpivirine of efavirenz over 96 weeks in the ECHO and THRIVE trials Tebas, P.; Sension, M.; Arribas, J.; Duiculescu, D.; Florence, E.; Hung, C. C.; Wilkin, T.; Vanveggel, S.; Stevens, M.; Deckx, H. Clinical Infectious Diseases 2014 Article
Antiretroviral drug resistance profiles and response to second-line therapy among HIV Type 1-infected Ugandan children Musiime, V.; Kaudha, E.; Kayiwa, J.; Mirembe, G.; Odera, M.; Kizito, H.; Nankya, I.; Ssali, F.; Kityo, C.; Colebunders, R.; Mugyenyi, P. AIDS Research and Human Retroviruses 2013 Article
Diaryltriazine non-nucleoside reverse transcriptase inhibitors are potent candidates for pre-exposure prophylaxis in the prevention of sexual HIV transmission Ariën, K. K.; Venkatraj, M.; Michiels, J.; Joossens, J.; Vereecken, K.; Van der Veken, P.; Abdellati, S.; Cuylaerts, V.; Crucitti, T.; Heyndrickx, L.; Heeres, J.; Augustyns, K.; Lewi, P. J.; Vanham, G. Journal of Antimicrobial Chemotherapy 2013 Article
Nucleoside reverse transcriptase inhibitor resistance mutations associated with first-line stavudine-containing antiretroviral therapy: programmatic implications for countries phasing out stavudine Tang, M. W.; Rhee, S. Y.; Bertagnolio, S.; Ford, N.; Holmes, S.; Sigaloff, K. C.; Hamers, R. L.; Rinke de Wit, T. F.; Fleury, H. J.; Kanki, P. J.; Ruxrungtham, K.; Hawkins, C. A.; Wallis, C. L.; Stevens, W.; van Zyl, G. U.; Manosuthi, W.; Hosseinipour, M. C.; Ngo-Giang-Huong, N.; Belec, L.; Peeters, M.; Aghokeng, A.; Bunupuradah, T.; Burdah, S.; Cane, P.; Cappelli, G.; Charpentier, C.; Dagnra, A. Y.; Deshpande, A. K.; El-Katib, Z.; Eshleman, S. H.; Fokam, J.; Gody, J. C.; Katzenstein, D.; Koyalta, D. D.; Kumwenda, J. J.; Lallemant, M.; Lynen, L.; Marconi, V. C.; Margot, N. A.; Moussa, S.; Ndung'u, T.; Nyambi, P. N.; Orrell, C.; Schapiro, J. M.; Schuurman, R.; Sirivichayakul, S.; Smith, D.; Zolfo, M.; Jordan, M. R.; Shafer, R. W. Journal of Infectious Diseases 2013 Article
Genotypic impact of prolonged detectable HIV-1 RNA viral load after HAART failure in a CRF01_AE infected cohort Zolfo, M.; Schapiro, J.; Phan, V.; Koole, O.; Thai, S.; Vekemans, M.; Fransen, K.; Lynen, L. AIDS Research and Human Retroviruses 2011 Article
Antiretroviral treatment in the private sector in Namibia Van der Veen, F.; Mugala-Mukungu, F.; Kangudi, M.; Feris, A.; Katjitae, I.; Colebunders, R. International Journal of STD & AIDS 2011 Article
Decrease of vitamin D concentration in patients with HIV infection on a non nucleoside reverse transcriptase inhibitor containing regimen Conesa-Botella, A.; Florence, E.; Lynen, L.; Colebunders, R.; Menten, J.; Moreno-Reyes, R. AIDS Research and Therapy 2010 Article-E
Sustained HIV RNA suppression after switching from enfuvirtide to etravirine in the early access programme [letter] Loutfy, M.; Ribera, E.; Florence, E.; De Wit, S.; Castagna, A.; Ryan, R.; Hill, A.; Vanaken, H.; van Delft, Y.; Marks, S. Journal of Antimicrobial Chemotherapy 2009 Letter
Pediatric HIV infection: the state of antiretroviral therapy McKellar, M. S.; Callens, S. F. J.; Colebunders, R. Expert Review of Anti-infective Therapy 2008 Article
When to switch for antiretroviral treatment failure in resource-limited settings? [editorial] Vekemans, M.; John, L.; Colebunders, R. AIDS 2007 Editorial
First-line antiretroviral therapy in Africa; how evidence-based are our recommendations? Colebunders, R.; Kamya, M. R.; Laurence, J.; Kambugu, A.; Byakwaga, H.; Songa Mwebaze, P.; Muganzi Muganga, A.; Katwere, M.; Katabira, E.; Muganzi, A. AIDS Reviews 2005 Article
Clinical and laboratory guidelines for the use of HIV-1 drug resistance testing as part of treatment management: recommendations for the European setting Unknown author AIDS 2001 Article